Inventor · disambiguated record
Douglas F. Nixon
Also filed as: NIXON DOUGLAS · NIXON DOUGLAS F · NIXON DOUGLAS FRASER
14 granted patents·5 pending applications·77 citations·filing 1991–2019
91Inventor score
Files withDAVID GLADSTONE INST5UNITED BIOMEDICAL INC5UNIV CALIFORNIA2CHILDRENS NAT MEDICAL CT1JONES RICHARD B1
Top patents by PatentIndex Score
19 records- 0177US10981976B2Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) and use thereofUNIV ROCHESTER·Filed 2017·Granted Apr 20, 2021·2 cites·10 claims
- 0275US7364869B2Method of detecting antigen-specific T lymphocytesDAVID GLADSTONE INST·Filed 2004·Granted Apr 29, 2008·24 cites·13 claims
- 0371US9416165B2Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitorsJONES RICHARD B·Filed 2008·Granted Aug 16, 2016·2 cites·6 claims
- 0464US6673556B2Methods of detecting specific cell lysisDAVID GLADSTONE INST·Filed 2001·Granted Jan 6, 2004·8 cites·10 claims
- 0559US9084762B2T-cell immunogens derived from anti-viral proteins and methods of using sameNIXON DOUGLAS F·Filed 2009·Granted Jul 21, 2015·0 cites·10 claims
- 0657US2008171061A1Human endogenous retrovirus polypeptide compositions and methods of use thereofNIXON DOUGLAS·Filed 2007·Application pending·0 cites
- 0754US2011046042A1Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use ThereofDAVID GLADSTONE INST·Filed 2008·Application pending·0 cites
- 0853US2013323279A1Human Endogenous Retrovirus Polypeptide Compositions and Methods of Use ThereofDAVID GLADSTONE INST·Filed 2013·Application pending·0 cites
- 0951US11261231B2Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitorsUNIV CALIFORNIA·Filed 2016·Granted Mar 1, 2022·0 cites·7 claims
- 1050US9572873B2Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteinsUNIV CALIFORNIA·Filed 2015·Granted Feb 21, 2017·0 cites·13 claims
- 1150US7186516B2Methods of detecting specific cell lysisDAVID GLADSTONE INST·Filed 2003·Granted Mar 6, 2007·1 cites·24 claims
- 1250US5700635AHIV-1 gag cytotoxic T-lymphocyte epitope and method of useUNITED BIOMEDICAL INC·Filed 1994·Granted Dec 23, 1997·8 cites·7 claims
- 1347US5480967AHIV-1 core protein fragmentsUNITED BIOMEDICAL INC·Filed 1991·Granted Jan 2, 1996·13 cites·8 claims
- 1443US5459238APeptide fragments of HIVUNITED BIOMEDICAL INC·Filed 1992·Granted Oct 17, 1995·4 cites·2 claims
- 1543US2022048988A1Cells expressing antibodies targeting human immunodeficiency virus and methods of using the sameCHILDRENS NAT MEDICAL CT·Filed 2019·Application pending·0 cites
- 1641US5395751AAssay for cytotoxic T cellsUNITED BIOMEDICAL INC·Filed 1991·Granted Mar 7, 1995·10 cites·7 claims
- 1738US2019069528A1Engineered human hookworms as a novel biodelivery system for vaccines and biologicalsUNIV GEORGE WASHINGTON·Filed 2017·Application pending·0 cites
- 1837US5683701APeptide fragments of HIVUNITED BIOMEDICAL INC·Filed 1994·Granted Nov 4, 1997·2 cites·3 claims
- 1933US5700469AHIV-1 core protein fragmentsMEDICAL RES COUNCIL·Filed 1995·Granted Dec 23, 1997·3 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →